Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment.

× No keyword cloud information.

7 in total

1. Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR).

Authors: J C Pastor; E Rodríguez; M A Marcos; M I Lopez
Journal: Ophthalmic Res Date: 2000 Jan-Feb Impact factor: 2.892

2. Comment on 'Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy'.

Authors: N V Radke; T K Panakanti; S N Radke; R Ravikoti
Journal: Eye (Lond) Date: 2014-08-08 Impact factor: 3.775

Review 3. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?

Authors: Steven Pennock; Luis J Haddock; Dean Eliott; Shizuo Mukai; Andrius Kazlauskas
Journal: Prog Retin Eye Res Date: 2014-01-09 Impact factor: 21.198

4. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy.

Authors: P E Rubsamen; S W Cousins
Journal: Retina Date: 1997 Impact factor: 4.256

5. Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.

Authors: K Ghasemi Falavarjani; M Hashemi; M Modarres; A Hadavand Khani
Journal: Eye (Lond) Date: 2014-02-21 Impact factor: 3.775

6. Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors: Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal: Am J Pathol Date: 2013-04-09 Impact factor: 4.307

7. Postoperative retinal fibrosis--a controlled clinical study of systemic steroid therapy.

Authors: F Koerner; A Merz; B Gloor; E Wagner
Journal: Graefes Arch Clin Exp Ophthalmol Date: 1982 Impact factor: 3.117

7 in total

1 in total

1. Dabigatran and Wet AMD, Results From Retinal Pigment Epithelial Cell Monolayers, the Mouse Model of Choroidal Neovascularization, and Patients From the Medicare Data Base.

Authors: Tanjina Akter; Balasubramaniam Annamalai; Elisabeth Obert; Kit N Simpson; Bärbel Rohrer
Journal: Front Immunol Date: 2022-06-17 Impact factor: 8.786

1 in total